Related Experiment Videos
Digoxin-quinidine interaction in patients with renal failure
Klinische Wochenschrift
|May 15, 1981
Summary
Quinidine significantly increases serum digoxin levels in patients with renal failure, suggesting uremic intoxication, not just reduced kidney function, influences this effect. This finding is crucial for managing digoxin therapy in kidney disease patients.
Area of Science:
- Pharmacology
- Nephrology
- Clinical Medicine
Background:
- Digoxin is a crucial medication for heart failure and arrhythmias.
- Renal impairment can significantly alter digoxin pharmacokinetics.
- Quinidine is known to interact with digoxin, but its effect in renal failure requires clarification.
Purpose of the Study:
- To investigate the impact of quinidine on serum digoxin concentrations in patients with renal failure.
- To compare these effects with those observed in normal subjects.
- To elucidate the mechanisms underlying the quinidine-digoxin interaction in renal impairment.
Main Methods:
- A study involving fifteen patients with renal failure receiving quinidine and digoxin.
- Monitoring of serum digoxin levels before and during quinidine administration.
- Assessment of renal function using creatinine clearance.
- Comparison between hemodialyzed and conservatively treated patients.
Main Results:
- Fourteen of fifteen patients exhibited a significant increase in serum digoxin levels after four days of quinidine.
- A correlation between creatinine clearance and the rise in serum digoxin was observed in non-hemodialyzed patients.
- Hemodialyzed patients did not show higher digoxin levels compared to conservatively treated patients.
Conclusions:
- Quinidine elevates serum digoxin levels in renal failure patients.
- The effect is not solely due to decreased renal digoxin clearance.
- Uremic intoxication severity may be a key factor in the observed correlation between renal function and digoxin levels.